Medicines Australia has
provided a supplementary
submission to the Senate Inquiry
into Corporate Tax Avoidance,
which has seen senior executives
from pharmaceutical companies
operating here accused of trying to
minimise tax (PD 30 Jun).
MA says it’s aiming to “address
a number of key misconceptions
which have arisen from the
July hearing,” giving a detailed
breakdown of the rules relating to
transfer pricing.
“It also seeks to clarify the role
of senior executives in the pricing
process and also outlines how the
PBS provides a government subsidy
to patients, not companies.
“Medicines Australia is
determined to eradicate these
misconceptions which have been
left to stand without scrutiny,” the
organisation said in a statement
issued late last night.The above article was sent to subscribers in Pharmacy Daily's issue from 24 Jul 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 24 Jul 15
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.